JOSEPH KIST
Dermatology Physician in PHILADELPHIA, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
JOSEPH KIST reported a CMS MIPS final score of 85.4852/100 — above the 83.1 national average — and filed 868 Medicare Part D claims in 2023.
- 85.4852/100
- MIPS score · +2 vs avg
- 868
- Part D claims, 2023
- 88%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
JOSEPH KIST's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
85 49th percentile higher than 49% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
JOSEPH KIST practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about JOSEPH KIST?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Pennsylvania
How Dermatology Physician compares to other specialties among Pennsylvania providers
Dermatology Physician share within Pennsylvania
Dermatology Physician is one of the more visible NUCC categories in Pennsylvania
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
JOSEPH KIST's 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 85.4852/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Dermatology Physician) — 85.4852/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Dermatology Physician US NPIs
85.4852/100 MIPS final score — 2.4 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Dermatology Physician. Quality dim: 73.6095.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JOSEPH KIST appears in the CMS NPPES registry as a Dermatology Physician provider at 3400 SPRUCE ST, PHILADELPHIA, PA, 19104, with a listed phone of (215) 662-2737. NPI 1134148687 was issued on 07/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KIST most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 868 prescription claims written by this provider, covering 332 Medicare beneficiaries and totaling roughly $259K in drug spend, split 12% brand-name and 88% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 85.4852/100 for the 2023 performance year (Quality 73.6095), compared with the national average of 83.1.
Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1134148687 |
|---|---|
| Specialty | Dermatology Physician |
| Gender | Male |
| NPI Issued | 07/18/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JOSEPH KIST's current license status, disciplinary history, and board certifications with the Pennsylvania State Board of Medicine in Pennsylvania before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where JOSEPH KIST bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context — Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to JOSEPH KIST. To verify JOSEPH KIST's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
12% brand-name claims vs 88% generic, on 868 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,123
- Total Day Supply
- 29,190
- Brand vs Generic
- 12% brand / 88% generic
- Brand Drug Cost
- $229K
- Generic Drug Cost
- $30K
- Antibiotic Claims
- 67
Patient Demographics
- Average Patient Age
- 74.6 years
- Avg HCC Risk Score
- 1.17
- Gender Split
- 50% female / 50% male
- Age Distribution
- <65: 12, 65-74: 159, 75-84: 129, 85+: 32
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What JOSEPH KIST prescribes most
Top Medicare Part D drugs by claim count, 2023
- Triamcinolone Acet…
Triamcinolone Acetonide
129 claims
- Ketoconazole
Ketoconazole
124 claims
- Hydrocortisone
Hydrocortisone
92 claims
- Mupirocin
Mupirocin
75 claims
- Dupixent Pen
Dupixent Pen
53 claims
- Fluorouracil 47
Fluorouracil
47 claims
- Nystatin 27
Nystatin
27 claims
- Doxycycline Hyclate 25
Doxycycline Hyclate
25 claims
| Drug | Claims |
|---|---|
| Triamcinolone Acetonide | 129 |
| Ketoconazole | 124 |
| Hydrocortisone | 92 |
| Mupirocin | 75 |
| Dupixent Pen Dupilumab | 53 |
| Fluorouracil | 47 |
| Nystatin | 27 |
| Doxycycline Hyclate | 25 |
| Fluocinolone Acetonide | 25 |
| Ciclopirox Ciclopirox Olamine | 24 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How JOSEPH KIST fits within the Dermatology Physician landscape nationally.
JOSEPH KIST's 868 claims are above the specialty average of 729.
Nearby Dermatology Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as KIST.
Compare Dermatology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Pennsylvania
Frequently Asked Questions
What is JOSEPH KIST's specialty? ▼
How much does JOSEPH KIST prescribe under Medicare Part D? ▼
What is JOSEPH KIST's Medicare quality score? ▼
Where is JOSEPH KIST located? ▼
What is JOSEPH KIST's NPI number? ▼
Does JOSEPH KIST prescribe more brand-name or generic drugs? ▼
How many Dermatology Physician providers are there in the US? ▼
What drugs does JOSEPH KIST prescribe most often? ▼
Does JOSEPH KIST accept Medicare? ▼
How can I verify JOSEPH KIST's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology